lobbying_activities: 1371737

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1371737	f565d07a-5a93-40c9-ac40-7c001e8623a3	Q1	ALFRED W. CORS, JR	285277	RETIRESAFE	2013	first_quarter	MMM	Support H.R. 351 and S.351 to repeal the Medicare Independent Payment Advisory Board mandated by the Affordable Care Act Oppose any reduction of Medicare Part B drug and biologic reimbursement payments that will harm patients. Support robust Part D formularies and continued coverage of the six protected classes. Support raising the Part D specialty tier cost-sharing threshold above the $600 minimum, and to at least index it to inflation.Support strong Part D oversight and improved transparency for consumers, as well as a better process for notice of non-coverage, for appeals, and exceptions to provide the best access to necessary, life-saving prescription medications. Support changes to the Part D Program that would address gaps in coverage, eliminate onerous cost-shifting through the use of specialty tiers and restrictive utilization management tools. Support any changes that improve the effectiveness of the program for those receiving low income subsidies. Support the most stringent safety requirements for any substitution of biosimilar drugs for any prescribed biologic, including notification of both the patient and the prescribing physician. Oppose any cuts to the Medicare Part D Program or any legislation requiring the Secretary of Health and Human Services to "negotiate" Part D prices or rebates that will forever limit access to the best drugs and biologics for Medicare beneficiaries.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	7040		0	0	2013-04-15T11:07:48.810000-04:00